|
Analyst Comments: EOG Resources, Altria Group, Entergy Corp., McDonald, King Pharma, PACCAR, Hurray Holding, Hittite Microwave, Hallmark Financial, Anadigics
We continue to see EOG Resources, Inc. (EOG) shares as a core holding in the large-cap exploration and production (E&P) space for the company?s demonstrated ability to achieve consistent production growth, primarily through organic means. EOG?s strong positions in Texas Barnett Shale and North Dakota?s Bakken plays provide it with a multi-year inventory of development drilling opportunities. EOG has a very strong organic production-growth profile, with volumes expected to increase by approximately 15% in 2008. We are keeping our recommendation, price objective and estimates unchanged at this stage. Long-term production-growth visibility has significantly improved following recent discoveries, and the management is guiding towards annual growth of approximately 14% in the 2009-2010 period. Outside North America, EOG has taken modest [More...] |
|
|
Analyst Comments: Acorda Therapeutics, GATX Corporation, Nova Chemical, ABM Industries, American Capital, Hallmark, Orbcomm, SiRF, XTO Energy, Genentech, Cyclacel Pharma, Nexen
We downgrade Acorda Therapeutics, Inc. (ACOR) to Sell from Hold, as we believe the shares are significantly overvalued at the current level, and expectations for profitability and future cash flow are entirely too high. We believe alternative medications and a high side-effect profile will keep Fampridine-SR as a niche-use drug only....
[More...] |
